The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Patel, Anand
One or more keywords matched the following properties of Patel, Anand
PropertyValue
keywords Myelodysplastic-Myeloproliferative Diseases
overview Dr. Patel is an expert in the treatment of myeloproliferative neoplasms, myelodysplastic syndromes, and leukemia. He is an active researcher whose work is focused on the development of clinical trials to investigate novel therapies that may improve the standard of care for patients with myeloid cancers and leukemia. Dr. Patel has published his research in several well-respected peer-reviewed journals including Blood, Blood Advances, the British Journal of Haematology, Cancer, JCI Insight, and Bone Marrow Transplantation.
One or more keywords matched the following items that are connected to Patel, Anand
Item TypeName
Concept Myeloproliferative Disorders
Concept Neoplasm Staging
Concept Lung Neoplasms
Concept Biomarkers, Tumor
Concept Drug Resistance, Neoplasm
Concept Neoplasms, Second Primary
Concept Neoplasm Recurrence, Local
Concept Hematologic Neoplasms
Concept Tumor Microenvironment
Concept Cell Line, Tumor
Concept Neoplasm Grading
Concept Neoplasms
Concept Tumor Suppressor Protein p53
Concept Neoplasm, Residual
Academic Article Clinical outcomes of IDH2-mutated advanced-phase Ph-negative myeloproliferative neoplasms treated with enasidenib.
Academic Article Biology and Treatment Paradigms in T Cell Acute Lymphoblastic Leukemia in Older Adolescents and Adults.
Academic Article The Next Generation of JAK Inhibitors: an Update on Fedratinib, Momelotonib, and Pacritinib.
Academic Article Genomics of MPN progression.
Academic Article Cedazuridine/decitabine: from preclinical to clinical development in myeloid malignancies.
Academic Article Provider-Level Barriers to Human Papillomavirus Vaccination in Survivors of Childhood and Young Adult Cancers.
Academic Article Therapy-related myeloid neoplasms in 109 patients after radiation monotherapy.
Academic Article Clinical and Biological Prognostic Factors in Follicular Lymphoma.
Academic Article FOXM1 contributes to treatment failure in acute myeloid leukemia.
Academic Article Insight into Sweet's syndrome and associated-malignancy: a review of the current literature.
Academic Article Paraneoplastic Thrombocytopenia.
Academic Article Impact of race on outcomes in intermediate-risk acute myeloid leukemia.
Academic Article Sequencing of novel agents in relapsed/refractory B-cell acute lymphoblastic leukemia: Blinatumomab and inotuzumab ozogamicin may have comparable efficacy as first or second novel agent therapy in relapsed/refractory acute lymphoblastic leukemia.
Academic Article Outcomes of TP53-mutated AML with evolving frontline therapies: Impact of allogeneic stem cell transplantation on survival.
Academic Article Disparities in receiving disease-directed therapy, allogeneic stem cell transplantation in non-Hispanic Black patients with TP53-mutated acute myeloid leukemia.
Academic Article Targeted Therapy for MPNs: Going Beyond JAK Inhibitors.
Academic Article Survival of TP53-mutated acute myeloid leukemia patients receiving allogeneic stem cell transplantation after first induction or salvage therapy: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND).
Academic Article SOHO State of the Art Updates and Next Questions | Accelerated Phase of MPN: What It Is and What to Do About It.
Academic Article Novel Therapies in Myelodysplastic Syndrome: Where Do Venetoclax and Isocitrate Dehydrogenase Inhibitors Fit in?
Academic Article Dual Targeting of Apoptotic and Signaling Pathways in T-Lineage Acute Lymphoblastic Leukemia.
Academic Article Measurable residual disease conversion rate with consolidation chemotherapy in acute myeloid leukemia.
Academic Article Trans-vaccenic acid reprograms CD8+ T cells and anti-tumour immunity.
Academic Article Durable responses in acute lymphoblastic leukaemia with the use of FLT3 and IDH inhibitors.
Academic Article Acute lymphoblastic leukemia with myeloid mutations is a high-risk disease associated with clonal hematopoiesis.
Academic Article Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND).
Academic Article Treatment outcomes of venetoclax-combination regimens for relapsed/refractory myeloid malignancies after anti-CD47-directed therapy.
Academic Article Expedited evaluation of hereditary hematopoietic malignancies in the setting of stem cell transplantation.
Academic Article Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era.
Search Criteria
  • Myeloproliferative
  • neoplasms
  • MPN